Study of Efficacy and Safety in Premenopausal Women With Hormone Receptor Positive, HER2-negative Advanced Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Advanced Metastatic Breast Cancer
Interventions: DRUG: LEE011|DRUG: Tamoxifen|DRUG: Letrozole|DRUG: Anastrozole|DRUG: Goserelin|DRUG: LEE011 Placebo
Sponsor: Novartis Pharmaceuticals